Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02112916 · FLOW

Participant flow

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma · Source last updated 2026-07-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Patients receive combination chemotherapy without bortezomib.
    id
    FG000
    title
    Arm A (Combination Chemotherapy): T-ALL
  2. description
    Patients received combination therapy with bortezomib (4 doses at 1.3mg/m2 during Induction and 4 doses at 1.3mg/m2 during Delayed Intensification)
    id
    FG001
    title
    Arm B (Combination Chemotherapy, Bortezomib): T-ALL
  3. description
    Patients receive combination chemotherapy without bortezomib.
    id
    FG002
    title
    Arm A (Combination Chemotherapy): T-LLy
  4. description
    Patients received combination therapy with bortezomib (4 doses at 1.3mg/m2 during Induction and 4 doses at 1.3mg/m2 during Delayed Intensification)
    id
    FG003
    title
    Arm B (Combination Chemotherapy, Bortezomib): T-LLy
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        2
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        4
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      type
      Lost to Follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        94
      2. group Id
        FG001
        num Subjects
        72
      3. group Id
        FG002
        num Subjects
        24
      4. group Id
        FG003
        num Subjects
        15
      type
      Physician Decision
    5. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        1
      type
      Withdrawal by Subject
    6. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        8
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        8
      type
      Ineligible
    7. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        5
      4. group Id
        FG003
        num Subjects
        5
      type
      Inevaluable
    8. reasons
      1. group Id
        FG000
        num Subjects
        19
      2. group Id
        FG001
        num Subjects
        16
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        7
      type
      Refusal of further protocol therapy
    9. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        1
      type
      Development of SMN
    10. reasons
      1. group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        18
      3. group Id
        FG002
        num Subjects
        15
      4. group Id
        FG003
        num Subjects
        2
      type
      Relapse/Progression
    11. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        5
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      type
      VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks
    12. reasons
      1. group Id
        FG000
        num Subjects
        44
      2. group Id
        FG001
        num Subjects
        47
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        2
      type
      Still on Therapy
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        312
      2. group Id
        FG001
        num Subjects
        315
      3. group Id
        FG002
        num Subjects
        111
      4. group Id
        FG003
        num Subjects
        109
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        108
      2. group Id
        FG001
        num Subjects
        123
      3. group Id
        FG002
        num Subjects
        52
      4. group Id
        FG003
        num Subjects
        62
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        204
      2. group Id
        FG001
        num Subjects
        192
      3. group Id
        FG002
        num Subjects
        59
      4. group Id
        FG003
        num Subjects
        47
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Patients receive combination chemotherapy without bortezomib.
    id
    FG000
    title
    Arm A (Combination Chemotherapy): T-ALL
  2. description
    Patients received combination therapy with bortezomib (4 doses at 1.3mg/m2 during Induction and 4 doses at 1.3mg/m2 during Delayed Intensification)
    id
    FG001
    title
    Arm B (Combination Chemotherapy, Bortezomib): T-ALL
  3. description
    Patients receive combination chemotherapy without bortezomib.
    id
    FG002
    title
    Arm A (Combination Chemotherapy): T-LLy
  4. description
    Patients received combination therapy with bortezomib (4 doses at 1.3mg/m2 during Induction and 4 doses at 1.3mg/m2 during Delayed Intensification)
    id
    FG003
    title
    Arm B (Combination Chemotherapy, Bortezomib): T-LLy
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        2
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        4
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      type
      Lost to Follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        94
      2. group Id
        FG001
        num Subjects
        72
      3. group Id
        FG002
        num Subjects
        24
      4. group Id
        FG003
        num Subjects
        15
      type
      Physician Decision
    5. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        1
      type
      Withdrawal by Subject
    6. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        8
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        8
      type
      Ineligible
    7. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        5
      4. group Id
        FG003
        num Subjects
        5
      type
      Inevaluable
    8. reasons
      1. group Id
        FG000
        num Subjects
        19
      2. group Id
        FG001
        num Subjects
        16
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        7
      type
      Refusal of further protocol therapy
    9. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        1
      type
      Development of SMN
    10. reasons
      1. group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        18
      3. group Id
        FG002
        num Subjects
        15
      4. group Id
        FG003
        num Subjects
        2
      type
      Relapse/Progression
    11. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        5
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      type
      VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks
    12. reasons
      1. group Id
        FG000
        num Subjects
        44
      2. group Id
        FG001
        num Subjects
        47
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        2
      type
      Still on Therapy
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        312
      2. group Id
        FG001
        num Subjects
        315
      3. group Id
        FG002
        num Subjects
        111
      4. group Id
        FG003
        num Subjects
        109
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        108
      2. group Id
        FG001
        num Subjects
        123
      3. group Id
        FG002
        num Subjects
        52
      4. group Id
        FG003
        num Subjects
        62
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        204
      2. group Id
        FG001
        num Subjects
        192
      3. group Id
        FG002
        num Subjects
        59
      4. group Id
        FG003
        num Subjects
        47
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice